Host-directed therapies: a potential solution to combat COVID-19

Expert Opin Biol Ther. 2020 Oct;20(10):1117-1120. doi: 10.1080/14712598.2020.1807001. Epub 2020 Aug 12.

Abstract

Coronavirus disease 2019 (COVID-19) characterized by immuno-pathological host responses including pneumonia, lymphopenia, and cytokine storm that leads to severe lung inflammation, developed in acute respiratory distress syndrome (ARDS). In the absence of an effective vaccine or any definitive cure, the use of host-directed therapies is an effective alternative and demanding treatment option in the current pandemic outbreak of COVID-19.

Keywords: Covid-19; Infectious disease; SARS-CoV-2; host-directed.

Publication types

  • Editorial

MeSH terms

  • Betacoronavirus / immunology*
  • COVID-19
  • Coronavirus Infections / therapy*
  • Humans
  • Immunotherapy*
  • Pandemics
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2